In recent years, South Africa’s pharmaceutical industry has increasingly shifted its focus to become more patient-centric in everything that it does.
However, in the current challenging economy, building on this positive change and delivering greater results for consumers is becoming ever more challenging. Companies operating in this sector will therefore need to adapt and embrace new strategies.
The road ahead for the pharma industry
No one knows this better than industry veteran, Jacques van Staden, COO of Cipla South Africa (Pty) Limited (“Cipla Medpro”), wholly-owned subsidiary of Cipla Limited, India (“Cipla”). With a career spanning more than 25 years, Van Staden firmly believes that pharmaceutical businesses will need to make significant changes to the way that they view opportunities and focus their efforts if they are to survive in the years to come. We sat down with Van Staden to hear more about the changes, challenges and opp